| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.21 | 0.1 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.23 | 0.1 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.1 |